Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL.
Zhou W, Miao J, Cheng Z, Wang Z, Wang J, Guo H, Wang P, Lu S, Si L, Zhang Z, Dunmall LC, Liu Y, Lemoine NR, Wang Y.
Zhou W, et al. Among authors: wang z, wang j, wang y, wang p.
Mol Ther Oncolytics. 2023 Aug 18;30:216-226. doi: 10.1016/j.omto.2023.08.009. eCollection 2023 Sep 21.
Mol Ther Oncolytics. 2023.
PMID: 37663131
Free PMC article.